(148 days)
For use in delivering intermittent positive pressure aerosol treatment on patients with a body weight greater than 30 kg (adults).
Piper IPPB™ Model 2055
I am sorry, but the provided text only contains an FDA 510(k) clearance letter and an "Indication for Use" statement for the Piper IPPB™ Model 2055. It does not include any information about acceptance criteria or a study proving that the device meets such criteria.
Therefore, I cannot provide the requested information. The document focuses on regulatory clearance based on substantial equivalence to a predicate device, rather than detailing performance studies and their acceptance criteria.
§ 868.5905 Noncontinuous ventilator (IPPB).
(a)
Identification. A noncontinuous ventilator (intermittent positive pressure breathing-IPPB) is a device intended to deliver intermittently an aerosol to a patient's lungs or to assist a patient's breathing.(b)
Classification. Class II (performance standards).